New research looks to the gut microbiome to try to address some of the symptoms associated with autism, but this investigation comes with its own set of problems.
The National Institute of Neurological Disorders and Stroke explain that "autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive and characteristic patterns of behavior and difficulties with social communication and interaction." They also point out that specialists use the term "spectrum," as autism is different in different individuals. The condition can incorporate a "wide range of symptoms, skills, and levels of disability in functioning."
Research has also found that autistic children often experience chronic gastrointestinal problems a lot more frequently than children without autism. This has led scientists from Arizona State University in Tempe to explore whether a fairly new form of therapy — microbiota transfer therapy (MTT) — can help solve gastrointestinal issues in autistic children. Also, they wanted to see whether this intervention could affect other autism markers. MTT involves collecting, processing, and freezing the fecal material of healthy people, and then administering it — orally or rectally — to the person receiving the treatment. Thus, the healthy bacteria should re-establish a balance in the gut microbiome of the person experiencing gastrointestinal problems.
The researchers explain that at the start of the study, autistic children had poorer bacterial diversity in the gut, compared with neurotypical children with healthy and balanced microbiota. More specifically, two beneficial bacterial strands — Bifidobacteria and Prevotella — were lacking in the microbiota of children on the spectrum. Following the initial MTT intervention, the autistic children experienced more gut bacterial diversity, including increased levels of Bifidobacteria and Prevotella. In the new clinical trial, which measured bacterial diversity in the gut after 2 years from the intervention, the children had even more bacterial diversity and a steady presence of healthful bacteria.
Showing posts with label gut microbiota. Show all posts
Showing posts with label gut microbiota. Show all posts
Friday, April 26, 2019
Friday, April 6, 2018
Gut Microbiota Influencing Obesity
Polyphenols may generate numerous health benefits by modulating the gut microbiota (GM). Phytochemicals that can influence GM have recently been studied as adjuvants to support healthy weight and inflammatory response. These phytochemicals include polyphenols and their derivatives, carotenoids, and thiosulfates, which were “further sub-classified into four main groups: flavonoids (including eight subgroups), phenolic acids (such as curcumin), stilbenoids (such as resveratrol), and lignans.”
“An imbalance of GM, or dysbiosis, can be the cause of, or at least lead to the progression of several pathologies such as infectious diseases, gastrointestinal cancers, cardiovascular disease, inflammatory bowel disease, and even obesity and diabetes.” Of the phytochemicals ingested, 90-95% “reach the colon in high concentrations, where they are degraded by the microbial enzymes prior to absorption.
Joining the ranks of prebiotics and probiotics, polyphenols are now attracting interest in the media and the research community as potential therapeutic agents in supporting health weight management. Proposed mechanisms of actions include “inhibition of the differentiation of adipocytes, increased fatty acid oxidation, decreased fatty acid synthesis, increased thermogenesis, the facilitation of energy metabolism and weight management, and the inhibition of digestive enzymes.
As promising as this is, more research is required to determine [the] role of micronutrients and phytochemicals as therapeutic agents in modulating the GM, and, therefore, influencing weight management and the inflammatory response.
My Take:
If you read the current (and all past editions) Guyton’s Physiology it states that the “role of the colon is to reabsorb water to create a formed stool.” We now understand that colon has many roles, the least of which is to create a formed stool.
“An imbalance of GM, or dysbiosis, can be the cause of, or at least lead to the progression of several pathologies such as infectious diseases, gastrointestinal cancers, cardiovascular disease, inflammatory bowel disease, and even obesity and diabetes.” Of the phytochemicals ingested, 90-95% “reach the colon in high concentrations, where they are degraded by the microbial enzymes prior to absorption.
Joining the ranks of prebiotics and probiotics, polyphenols are now attracting interest in the media and the research community as potential therapeutic agents in supporting health weight management. Proposed mechanisms of actions include “inhibition of the differentiation of adipocytes, increased fatty acid oxidation, decreased fatty acid synthesis, increased thermogenesis, the facilitation of energy metabolism and weight management, and the inhibition of digestive enzymes.
As promising as this is, more research is required to determine [the] role of micronutrients and phytochemicals as therapeutic agents in modulating the GM, and, therefore, influencing weight management and the inflammatory response.
My Take:
If you read the current (and all past editions) Guyton’s Physiology it states that the “role of the colon is to reabsorb water to create a formed stool.” We now understand that colon has many roles, the least of which is to create a formed stool.
Subscribe to:
Posts (Atom)